Safety and Antiviral Study of ACH-126, 443 (Beta-L-Fd4C) in the Treatment of Adults With Chronic Hepatitis B Infection.

This study has been terminated.

( Safety concerns from other studies. )

Study NCT00037622 Information provided by Achillion Pharmaceuticals

First Received: May 17, 2002 Last Updated: August 18, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been terminated.
Study Completion Date:	May 2003
Estimated Primary Completion Date:	No date given